« Back
Home /
Nelarabine

Nelarabine

Item no.	M1916-200mg
Manufacturer	AbMole
CASRN	121032-29-9
Amount	200mg
Category	Oncology Inhibitors & Compound Libraries Small Molecules By Organ Heart & Blood Cancer
Type	Inhibitors
Specific against	other
Purity	>99%
Citations	In vitro efficacy of forodesine and nelarabine (ara-G) in pediatric leukemia. Homminga I, et al . Blood. 2011 Aug 25,118(8):2184-90. PMID: 21730354 . Nelarabine for the treatment of patients with relapsed or refractory T-cell acute lymphoblastic leukemia or lymphoblastic lymphoma. DeAngelo DJ. Hematol Oncol Clin North Am. 2009 Oct,23(5):1121-35, vii-viii. PMID: 19825456 .
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	Arranon, 506U78
Similar products	Nelarabine, Arranon, 506U78
Available
Target Information	DNA/RNA Synthesis
Molecular Weight	297, 27
Solubility	DMSO ≥ 60 mg/mL
Bioactivity information	Nelarabine is a novel purine antimetabolite antineoplastic agent.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

M1916-200mg-safety-datasheet.pdf